These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 17519821)

  • 1. [Perspectives on allergic bronchopulmonary aspergillosis].
    Germaud P; Pipet A
    Rev Mal Respir; 2007 May; 24(5):659-61. PubMed ID: 17519821
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prolonged therapeutic response to voriconazole in a case of allergic bronchopulmonary aspergillosis].
    Bandrés Gimeno R; Muñoz Martínez MJ
    Arch Bronconeumol; 2007 Jan; 43(1):49-51. PubMed ID: 17257565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of voriconazole (UK-109,496) against clinical isolates of Aspergillus species and its effectiveness in an experimental model of invasive pulmonary aspergillosis.
    Murphy M; Bernard EM; Ishimaru T; Armstrong D
    Antimicrob Agents Chemother; 1997 Mar; 41(3):696-8. PubMed ID: 9056016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic necrotizing and allergic bronchopulmonary aspergillosis in an asthmatic patient--a therapeutic challenge.
    Jensen SG; Nielsen TL
    Clin Respir J; 2008 Oct; 2(4):245-6. PubMed ID: 20298342
    [No Abstract]   [Full Text] [Related]  

  • 5. [Allergic broncho-pulmonary aspergillosis treated with voriconazole].
    Mulliez P; Croxo C; Roy-Saint Georges F; Darras A
    Rev Mal Respir; 2006 Feb; 23(1 Pt 1):93-4. PubMed ID: 16604033
    [No Abstract]   [Full Text] [Related]  

  • 6. Case report: allergic bronchopulmonary aspergillosis and allergic fungal sinusitis successfully treated with voriconazole.
    Erwin GE; Fitzgerald JE
    J Asthma; 2007 Dec; 44(10):891-5. PubMed ID: 18097869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Voriconazole and posaconazole improve asthma severity in allergic bronchopulmonary aspergillosis and severe asthma with fungal sensitization.
    Chishimba L; Niven RM; Cooley J; Denning DW
    J Asthma; 2012 May; 49(4):423-33. PubMed ID: 22380765
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of ABPA: a place for voriconazole and omalizumab?].
    Mulliez P
    Rev Mal Respir; 2010 Sep; 27(7):670-2. PubMed ID: 20863965
    [No Abstract]   [Full Text] [Related]  

  • 9. Allergic bronchopulmonary aspergillosis--a clinical review.
    Gupta RK; Chandr A; Gautam PB
    J Assoc Physicians India; 2012 Apr; 60():46-51. PubMed ID: 23029742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Painful peripheral neuropathy associated with voriconazole during the treatment of chronic cavitary pulmonary aspergillosis].
    Gendrot A; de La Blanchardière A; de La Gastine B; Fromager G; Massias L; Verdon R
    Rev Med Interne; 2010 Feb; 31(2):163-6. PubMed ID: 19457596
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rebound after ABPA treatment with voriconazole].
    Mulliez P; Croxo C; Saint-Georges FR
    Rev Mal Respir; 2010 Sep; 27(7):786-7. PubMed ID: 20863984
    [No Abstract]   [Full Text] [Related]  

  • 12. [Allergic bronchopulmonary aspergillosis].
    Hodgson U
    Duodecim; 2010; 126(4):356-63. PubMed ID: 20486486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voriconazole in the treatment of allergic bronchopulmonary aspergillosis in cystic fibrosis.
    Glackin L; Leen G; Elnazir B; Greally P
    Ir Med J; 2009 Jan; 102(1):29. PubMed ID: 19284017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful control of exacerbation of Allergic Bronchopulmonary Aspergillosis due to Aspergillus terreus in a cystic fibrosis patient with short-term adjunctive therapy with voriconazole: A case report.
    Hassanzad M; Mortezaee V; Bongomin F; Poorabdollah M; Sharifynia S; Maleki M; Hedayati N; Velayati AA; Hedayati MT
    J Mycol Med; 2019 Jun; 29(2):189-192. PubMed ID: 30782501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis of allergic bronchopulmonary aspergillosis and an evidence-based review of azoles in treatment.
    Wark P
    Respir Med; 2004 Oct; 98(10):915-23. PubMed ID: 15481266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antimycotic treatment of pulmonary aspergilloma in patients without neutropenia].
    Grysczyk H; De Roux A; Grassot A; Mauch H; Lode H
    Dtsch Med Wochenschr; 2002 Mar; 127(10):492-6. PubMed ID: 11884987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis.
    Stevens DA; Schwartz HJ; Lee JY; Moskovitz BL; Jerome DC; Catanzaro A; Bamberger DM; Weinmann AJ; Tuazon CU; Judson MA; Platts-Mills TA; DeGraff AC
    N Engl J Med; 2000 Mar; 342(11):756-62. PubMed ID: 10717010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Susceptibility of fungi isolated from the respiratory tract of falcons to amphotericin B, itraconazole and voriconazole.
    Silvanose CD; Bailey TA; Di Somma A
    Vet Rec; 2006 Aug; 159(9):282-4. PubMed ID: 16946311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A lung mass: when the history helps the diagnosis.
    Bua J; Marchetti F; Zennaro F; Ventura A
    BMJ Case Rep; 2011 Oct; 2011():. PubMed ID: 22679144
    [No Abstract]   [Full Text] [Related]  

  • 20. [Cutaneous, pulmonary and bone aspergillosis in a patient presumed immunocompetent presenting subacute cutaneous lupus erythematosus].
    Domergue V; Orlandini V; Begueret H; Couprie B; Huerre M; Tunon de Lara M; Beylot-Barry M; Doutre MS
    Ann Dermatol Venereol; 2008 Mar; 135(3):217-21. PubMed ID: 18374855
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.